|
Paula Salmikangas PhD
Director of Biopharmaceuticals and ATMP
NDA Group AB
Finland
|
Paula Salmikangas is a Director of ATMPs and member of the Advisory Board at NDA. She is a clinical biochemist by training and holds a Ph.D. in molecular and cell biology. Dr. Salmikangas has background as a research scientist and she is an Adjunct Professor of Biochemistry for the University of Helsinki. Before joining NDA Dr. Salmikangas worked as a Research Professor at the Finnish Medicines Agency (2003-2017), acting as the Finnish member and Vice-Chair of the Committee for Advanced Therapies (CAT) at the European Medicines Agency from 2009 to 2014 and as the Chair of the CAT 2014-2017. She has also been the Chair of the Cell Products Working Party (CPWP) and a member of the Biologics Working Party (BWP). Her main areas of expertise are biological medicinal products, especially ATMPs, including CMC, regulatory and immunogenicity aspects of biopharmaceuticals.